z-logo
Premium
Inhibition profiles of Voriconazole against acetylcholinesterase, α‐glycosidase, and human carbonic anhydrase I and II isoenzymes
Author(s) -
Topal Fevzi
Publication year - 2019
Publication title -
journal of biochemical and molecular toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.526
H-Index - 58
eISSN - 1099-0461
pISSN - 1095-6670
DOI - 10.1002/jbt.22385
Subject(s) - chemistry , voriconazole , carbonic anhydrase , acetazolamide , acetylcholinesterase , isozyme , enzyme , tacrine , carbonic anhydrase i , ic50 , enzyme kinetics , aché , biochemistry , stereochemistry , pharmacology , active site , in vitro , medicine , biology , microbiology and biotechnology , antifungal
In this work, the inhibitory activity of Voriconazole was measured against some metabolic enzymes, including human carbonic anhydrase (hCA) I and II isoenzymes, acetylcholinesterase (AChE), and α‐glycosidase; the results were compared with standard compounds including acetazolamide, tacrine, and acarbose. Half maximal inhibition concentration (IC 50 ) values were obtained from the enzyme activity (%)‐[Voriconazole] graphs, whereas K i values were calculated from the Lineweaver‐Burk graphs. According to the results, the IC 50 value of Voriconazole was 40.77 nM for α‐glycosidase, while the mean inhibition constant ( K i ) value was 17.47 ± 1.51 nM for α‐glycosidase. The results make an important contribution to drug design and have pharmacological applications. In addition, the Voriconazole compound demonstrated excellent inhibitory effects against AChE and hCA isoforms I and II. Voriconazole had K i values of 29.13 ± 3.57 nM against hCA I, 15.92 ± 1.90 nM against hCA II, and 10.50 ± 2.46 nM against AChE.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom